Direct Oral Anticoagulants: An Overview for the Interventional Radiologist
- Aintree University Hospitals NHS Foundation Trust, Radiology Department (United Kingdom)
- Aintree University Hospitals NHS Foundation Trust, Haematology Department (United Kingdom)
The direct oral anticoagulants (DOACs) have emerged as a good alternative for the treatment of thromboembolic diseases, and their use in clinical practice is increasing rapidly. The DOACs act by blocking the activity of one single step in the coagulation cascade. These drugs act downstream in the common pathway of the coagulation cascade by directly antagonising the action of thrombin or factor Xa. The development of DOACs represents a paradigm shift from the oral vitamin K antagonists such as warfarin. This article aims to describe the properties of the currently available DOACs including pharmacology and dosing. We also address the strategies for periprocedural management and reversal of anticoagulation of patients treated with these agents.
- OSTI ID:
- 22645303
- Journal Information:
- Cardiovascular and Interventional Radiology, Vol. 40, Issue 3; Other Information: Copyright (c) 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); http://www.springer-ny.com; Country of input: International Atomic Energy Agency (IAEA); ISSN 0174-1551
- Country of Publication:
- United States
- Language:
- English
Similar Records
Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation?
Apixaban attenuates ischemia-induced myocardial fibrosis by inhibition of Gq/PKC signaling